<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: In type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> is detrimental to beta-cells, causing <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and <z:e sem="disease" ids="C0948379" disease_type="Disease or Syndrome" abbrv="">impaired insulin secretion</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The transcription factor cAMP-responsive element-binding protein (CREB) is crucial for beta-cell survival and function </plain></SENT>
<SENT sid="2" pm="."><plain>We investigated whether prolonged exposure of beta-cells to high <z:chebi fb="105" ids="17234">glucose</z:chebi> affects the functional integrity of CREB </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: INS-1E cells and rat and human islets were used </plain></SENT>
<SENT sid="4" pm="."><plain>Gene expression was analyzed by RT-PCR and Western blotting </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was detected by cleaved caspase-3 emergence, DNA fragmentation, and electron microscopy </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0011010'>Chronic</z:hpo> exposure of INS-1E cells and rat and human islets to high <z:chebi fb="105" ids="17234">glucose</z:chebi> resulted in decreased CREB protein expression, phosphorylation, and transcriptional activity associated with <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and impaired beta-cell function </plain></SENT>
<SENT sid="7" pm="."><plain>High-<z:chebi fb="105" ids="17234">glucose</z:chebi> treatment increased CREB polyubiquitination, while treatment of INS-1E cells with the <z:chebi fb="0" ids="52726">proteasome inhibitor</z:chebi> MG-132 prevented the decrease in CREB content </plain></SENT>
<SENT sid="8" pm="."><plain>The emergence of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in INS-1E cells with decreased CREB protein expression knocked down by small interfering <z:chebi fb="40" ids="33697">RNA</z:chebi> suggested that loss of CREB protein content induced by high <z:chebi fb="105" ids="17234">glucose</z:chebi> contributes to beta-cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Loading INS-1E cells or human islets with a cell-permeable <z:chebi fb="7" ids="16670">peptide</z:chebi> mimicking the proteasomal targeting sequence of CREB blocked CREB degradation and protected INS-1E cells and human islets from <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by high <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="10" pm="."><plain>The insulin secretion in response to <z:chebi fb="105" ids="17234">glucose</z:chebi> and the insulin content were preserved in human islets exposed to high <z:chebi fb="105" ids="17234">glucose</z:chebi> and loaded with the <z:chebi fb="7" ids="16670">peptide</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: These studies demonstrate that the CREB degradation by the ubiquitin-proteasome pathway contributes to <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> and <z:hpo ids='HP_0011420'>death</z:hpo> upon glucotoxicity and provide new insight into the cellular mechanisms of glucotoxicity </plain></SENT>
</text></document>